PREVENTION OF HIV/RELATED DISEASE AMONG MIAMI IV USERS

Project: Research project

Description

Miami has the fourth largest rate of AIDS in the U.S., and is
represented among all the major identified risk groups with AIDS.
Miami is also known as one of the major centers of illegal drug
activity, and has a significant proportion of AIDS cases among
intravenous (IV) drug users. The major goal of this proposal is to
evaluate a demonstration project designed to reduce risk behavior
of IV drug users relative to the development of HIV and HIV
related diseases (AIDS, ARC). Intervention Prevention Program
(AIDS PIP) will be implemented in the Miami metropolitan area,
by the AIDS research team of the Health Services Research
Center of the University of Miami School of Medicine. A
minimum of 1260 IV drug users will be recruited from three
sources of Miami non-treatment populations: (1) criminal justice
clients, (2) emergency room admissions, and (3) active IV users in
the "street" community. The three largest racial/ethnic groups
(Whites, Blacks and Hispanics) will be targeted for recruitment
into the tailored demonstration intervention program. A baseline
assessment will collect serum samples for determination of HIV
seropositivity, and detailed information on drug use, sexual
practices, and other information important for follow-up and
treatment. All subjects will be randomized into two levels of the
AIDS PIP. The first level provides the standard information about
transmission, and referral to existing drug and AIDS prevention
programs. The enhanced intervention level provides a much more
intensive intervention program emphasizing interactions on an
individualized and group basis, and includes sexual partners as an
important component of the PIP strategy. In addition, this level
will also provide training to indigenous outreach workers to be
used in this project Regularly scheduled interim assessments, and
a final one will determine the effectiveness of the program, as
well as delineate the processes by which the program was
effective.
StatusFinished
Effective start/end date9/30/8712/31/92

Funding

  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health

Fingerprint

Acquired Immunodeficiency Syndrome
HIV
Drug Users
Student Health Services
AIDS-Related Complex
Anti-HIV Agents
Sexual Partners
Health Services Research
Program Evaluation
Hispanic Americans
Ethnic Groups
Hospital Emergency Service
Referral and Consultation
Medicine
Serum
Pharmaceutical Preparations
Population